XTX Topco’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

XTX Topco’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-838	Closed	-$7.8K	–	2437
2023 Q4	$7.8K	Buy	+838	New	+$9.91K	﹤0.01%	1447

Other funds holding VCNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

XTX Topco's VCNX Position: Q1 2024 in Review

XTX Topco sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2024, closing a stake of 838 shares — an estimated $7.8K sold.

XTX Topco first reported a position in VCNX in Q4 2023 and held it in 1 quarter. The position peaked at $7.8K in Q4 2023. 12 funds tracked by Wall St. Rank hold VCNX as of Q1 2024.

XTX Topco reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
XTX Topco sold 838 Vaccinex, Inc. Common Stock shares in Q1 2024, an estimated $7.8K.
XTX Topco first reported a position in Vaccinex, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
XTX Topco's Vaccinex, Inc. Common Stock position peaked at $7.8K in Q4 2023.
12 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2024.

Based on XTX Topco's 13F filing for Q1 2024, filed 13 May 2024.